GB0805356D0 - Vaccine adjuvant composition - Google Patents
Vaccine adjuvant compositionInfo
- Publication number
- GB0805356D0 GB0805356D0 GB0805356A GB0805356A GB0805356D0 GB 0805356 D0 GB0805356 D0 GB 0805356D0 GB 0805356 A GB0805356 A GB 0805356A GB 0805356 A GB0805356 A GB 0805356A GB 0805356 D0 GB0805356 D0 GB 0805356D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- adjuvant composition
- vaccine adjuvant
- vaccine
- composition
- adjuvant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0805356A GB0805356D0 (en) | 2008-03-25 | 2008-03-25 | Vaccine adjuvant composition |
PCT/GB2009/000788 WO2009118523A1 (en) | 2008-03-25 | 2009-03-25 | Adjuvant |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0805356A GB0805356D0 (en) | 2008-03-25 | 2008-03-25 | Vaccine adjuvant composition |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0805356D0 true GB0805356D0 (en) | 2008-04-30 |
Family
ID=39386659
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0805356A Ceased GB0805356D0 (en) | 2008-03-25 | 2008-03-25 | Vaccine adjuvant composition |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0805356D0 (en) |
WO (1) | WO2009118523A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9603919B2 (en) | 2009-03-31 | 2017-03-28 | Japan As Represented By The Director-General Of National Institute Of Infectious Diseases | Method for prophylaxis of influenza using vaccine for intranasal administration |
MX342405B (en) | 2010-06-03 | 2016-09-28 | Pharmacyclics Inc | The use of inhibitors of bruton's tyrosine kinase (btk). |
AU2013293087B2 (en) | 2012-07-24 | 2017-08-31 | Pharmacyclics Llc | Mutations associated with resistance to inhibitors of Bruton's tyrosine kinase (BTK) |
KR20150080592A (en) | 2012-11-02 | 2015-07-09 | 파마시클릭스, 인코포레이티드 | Tec family kinase inhibitor adjuvant therapy |
WO2015143400A1 (en) | 2014-03-20 | 2015-09-24 | Pharmacyclics, Inc. | Phospholipase c gamma 2 and resistance associated mutations |
WO2017218819A1 (en) | 2016-06-17 | 2017-12-21 | Merial, Inc. | Novel immunogenic formulations comprising linear or branched polyacrylic acid polymer adjuvants |
WO2023120535A1 (en) * | 2021-12-20 | 2023-06-29 | 東興薬品工業株式会社 | Vaccine adjuvant agent containing polyacrylic acid polymer and use of same |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2775601B1 (en) * | 1998-03-03 | 2001-09-21 | Merial Sas | RECOMBINANT LIVING VACCINES AND ADJUVANTS |
FR2776928B1 (en) * | 1998-04-03 | 2000-06-23 | Merial Sas | ADJUVATED DNA VACCINES |
US20030104008A1 (en) * | 2001-04-06 | 2003-06-05 | Loosmore Sheena May | Recombinant vaccine against west nile virus |
US7862821B2 (en) * | 2006-06-01 | 2011-01-04 | Merial Limited | Recombinant vaccine against bluetongue virus |
DE602007010127D1 (en) * | 2006-06-01 | 2010-12-09 | Statens Seruminstitut | Hiv-impfstoff |
-
2008
- 2008-03-25 GB GB0805356A patent/GB0805356D0/en not_active Ceased
-
2009
- 2009-03-25 WO PCT/GB2009/000788 patent/WO2009118523A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2009118523A1 (en) | 2009-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1211870A1 (en) | Novel adjuvant compositions | |
HK1159485A1 (en) | Vaccine composition containing synthetic adjuvant | |
ZA201101481B (en) | Vaccine | |
EP2344522A4 (en) | Combination adjuvant formulation | |
HRP20151124T1 (en) | Vaccine | |
IL208660A0 (en) | Coccididosis vaccines | |
GB0810869D0 (en) | Vaccine adjuvant composition | |
GB0822001D0 (en) | Vaccine | |
GB0810710D0 (en) | Vaccine | |
ZA201007402B (en) | Vaccine | |
GB0805356D0 (en) | Vaccine adjuvant composition | |
GB0816284D0 (en) | Vaccine | |
EP2498815A4 (en) | Vaccine composition | |
EP2252326A4 (en) | Vaccine compositions | |
GB0816447D0 (en) | Vaccine | |
EP2254593A4 (en) | Immunogenic influenza composition | |
GB0801326D0 (en) | Vaccines | |
EP2337847A4 (en) | Vaccine adjuvants | |
GB0801122D0 (en) | Vaccine composition | |
GB0802326D0 (en) | Vaccine Composition | |
GB0820404D0 (en) | Vaccine compositions | |
GB0702363D0 (en) | Vaccine composition | |
GB0809781D0 (en) | Vaccine | |
GB0820478D0 (en) | Vaccine | |
GB0810914D0 (en) | Vaccine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |